Nanomix Overview
- Year Founded
-
2000
- Status
-
Private
- Employees
-
35
- Latest Deal Type
-
PIPE
- Latest Deal Amount
-
$8.4M
Nanomix General Information
Description
Nanomix Corp develops, manufactures, and commercializes point-of-care diagnostic tests that are used to detect or monitor diseases. Its products include The Nanomix eLab System, COVID-19 Rapid Antigen Panel, and Critical Infection and Host Response. The company's products improve healthcare delivery by bringing the diagnostic information to the point of initial patient interaction, whether in the hospital or settings such as nursing facilities, elderly homes, urgent care centers, airports, schools, and more.
Contact Information
Website
www.nanomixdx.comCorporate Office
- 2121 Williams Street
- San Leandro, CA 94577
- United States
Corporate Office
- 2121 Williams Street
- San Leandro, CA 94577
- United States
Nanomix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 21. PIPE | 29-Jun-2021 | $8.4M | Completed | Generating Revenue | ||
| 20. Reverse Merger | 04-Jun-2021 | Completed | Generating Revenue | |||
| 19. Debt - PPP | 27-Apr-2020 | Completed | Generating Revenue | |||
| 18. Grant | 08-Apr-2020 | Completed | Generating Revenue | |||
| 17. Secondary Transaction - Private | Completed | Clinical Trials - General | ||||
| 16. Accelerator/Incubator | 01-Jun-2019 | Completed | Clinical Trials - General | |||
| 15. Later Stage VC (Series EE) | 09-Nov-2017 | Completed | Clinical Trials - General | |||
| 14. Later Stage VC (Series DD) | 30-Jan-2014 | Completed | Clinical Trials - General | |||
| 13. Later Stage VC (Series CC) | 19-Aug-2011 | $6.35M | $56.9M | Completed | Clinical Trials - General | |
| 12. Later Stage VC (Series BB) | 02-Aug-2010 | $1.79M | $50.6M | Completed | Clinical Trials - General |
Nanomix Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series EE-2 | ||||||||
| Series EE-1 | ||||||||
| Series DD | ||||||||
| Series CC | ||||||||
| Series BB | 22,120,639 | $0.000010 | $0.01 | $0.08 | $0.08 | 1x | $0.08 | 17.2% |
| Series AA | 1,045,650 | $0.000010 | $0.09 | $1.15 | $4.6 | 4x | $1.15 | 0.81% |
Nanomix Comparisons
Industry
Financing
Details
Nanomix Competitors (12)
One of Nanomix’s 12 competitors is ACON Laboratories, a Corporate Backed or Acquired company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ACON Laboratories | Corporate Backed or Acquired | San Diego, CA | ||||
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| Radiometer Medical | Corporate Backed or Acquired | Bronshoj, Denmark | ||||
| Abbott Diagnostics | Failed Transaction (M&A) | Lake Forest, IL | ||||
| Micropoint | Formerly VC-backed | Santa Clara, CA |
Nanomix Signals
Nanomix Acquisitions (1)
Nanomix’s most recent deal was a Merger/Acquisition with Boston Therapeutics. The deal was made on 04-Jun-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Boston Therapeutics | 04-Jun-2021 | Merger/Acquisition | Pharmaceuticals |
Nanomix ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Nanomix FAQs
-
When was Nanomix founded?
Nanomix was founded in 2000.
-
Where is Nanomix headquartered?
Nanomix is headquartered in San Leandro, CA.
-
What is the size of Nanomix?
Nanomix has 35 total employees.
-
What industry is Nanomix in?
Nanomix’s primary industry is Diagnostic Equipment.
-
Is Nanomix a private or public company?
Nanomix is a Private company.
-
What is Nanomix’s current revenue?
The current revenue for Nanomix is .
-
How much funding has Nanomix raised over time?
Nanomix has raised $86.3M.
-
Who are Nanomix’s competitors?
ACON Laboratories, Illumina, Radiometer Medical, Abbott Diagnostics, and Micropoint are some of the 12 competitors of Nanomix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process